Unlocking TIL Therapy: A New Era for Melanoma Care in the UK

Wednesday 11 March 2026 - Midland Hotel, Manchester

What to expect

  • Recognise how biomarkers and the tumour microenvironment predict TIL response
  • Understand the core science and clinical development of TIL therapy
  • Learn key factors in patient selection, team coordination, and toxicity management.
  • Identify challenges in scaling TIL therapy across the NHS

Intended audience

Clinical staff (including clinical/medical oncologists, surgeons, haematologists, pathologists, radiologists), scientists, translational researchers, NHS policymakers and those who have an interest in this field.

Last updated: November 2025